These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17273904)

  • 1. Retinal break following an intravitreal triamcinolone acetonide injection.
    Erol N; Topbas S; Sahin A
    Int Ophthalmol; 2005; 26(4-5):163-5. PubMed ID: 17273904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
    Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
    Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
    Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
    Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal cortisone injection for refractory diffuse diabetic macular edema.
    Er H; Yilmaz H
    Ophthalmologica; 2005; 219(6):394-400. PubMed ID: 16286802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
    Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
    Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
    Jonas JB; Kreissig I; Kamppeter B; Degenring RF
    Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.
    Batioğlu F; Ozmert E; Parmak N; Celik S
    Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of intravitreal triamcinolone acetonide.
    Erol N; Topba S
    Surv Ophthalmol; 2009; 54(3):427; author reply 427-8. PubMed ID: 19422973
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravitreal triamcinolone for diabetic macular edema: comparison of 1, 2, and 4 mg.
    Hauser D; Bukelman A; Pokroy R; Katz H; Len A; Thein R; Parness-Yossifon R; Pollack A
    Retina; 2008 Jun; 28(6):825-30. PubMed ID: 18536598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Objective evaluation of cataract progression associated with a high dose intravitreal triamcinolone injection.
    Chu YK; Chung EJ; Kwon OW; Lee JH; Koh HJ
    Eye (Lond); 2008 Jul; 22(7):895-9. PubMed ID: 17435692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
    Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
    Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
    Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
    Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macular grid photocoagulation after intravitreal triamcinolone acetonide for diffuse diabetic macular edema.
    Kang SW; Sa HS; Cho HY; Kim JI
    Arch Ophthalmol; 2006 May; 124(5):653-8. PubMed ID: 16682586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
    Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C
    J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular morbidity associated with intravitreal triamcinolone acetonide.
    Konstantopoulos A; Williams CP; Newsom RS; Luff AJ
    Eye (Lond); 2007 Mar; 21(3):317-20. PubMed ID: 16710433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema.
    Wickremasinghe SS; Rogers SL; Gillies MC; Zhu M; Wong TY
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4707-11. PubMed ID: 18599569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema.
    Margolis R; Singh RP; Bhatnagar P; Kaiser PK
    Acta Ophthalmol; 2008 Feb; 86(1):105-10. PubMed ID: 17608830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.
    Audren F; Erginay A; Haouchine B; Benosman R; Conrath J; Bergmann JF; Gaudric A; Massin P
    Acta Ophthalmol Scand; 2006 Oct; 84(5):624-30. PubMed ID: 16965492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.